Adam Turpcu

Company: Adverum Biotechnologies

Job title: Senior Vice President - Clinical Development

Bio:

Adam Turpcu serves as Senior Vice President of Clinical Development at Adverum Biotechnologies, where he has contributed for six years to advancing gene therapy for ophthalmic disorders. With diverse expertise spanning clinical development, medical affairs, health economics, and commercial marketing, Adam has been instrumental in designing and executing Adverum’s clinical program from Phase I through Phase III trials. He led the design of the company’s first human study and currently oversees the Phase II LUNA trial and Phase III ARTEMIS trial for wet AMD treatment. Previously, Adam held positions at Clearside Biomedical and Genentech, bringing extensive experience in ophthalmology drug development and regulatory strategy.

Seminars:

Presenting Phase 2 Clinical Data on Adverum Biotechnologies WetAMD lxo-vec Therapy to Show Progress of Ophthalmic Gene Therapy 11:30 am

Iterating on capsid structure and dosing protocols to achieve the optimal efficacysafety balance while minimizing adverse events Leveraging regulatory pathways and collaborative agency relationships to accelerate development timelines Working strategically within FDA frameworks to demonstrate compelling efficacy data that meets regulatory expectationsRead more

day: Conference Day One